Beyond the AJR: Integrating 18F-Fluciclovine PET/CT Into Salvage Radiotherapy Planning for Recurrent Prostate Cancer Reduces Rates of Biochemical Failure (EMPIRE-1 Trial)
Abstract
Beyond the AJR: Integrating 18F-Fluciclovine PET/CT Into Salvage Radiotherapy Planning for Recurrent Prostate Cancer Reduces Rates of Biochemical Failure (EMPIRE-1 Trial)Samuel J. Galgano, MD1 and Jonathan McConathy, MD, PhD1Audio Available |...
Paper Details
Title
Beyond the AJR: Integrating 18F-Fluciclovine PET/CT Into Salvage Radiotherapy Planning for Recurrent Prostate Cancer Reduces Rates of Biochemical Failure (EMPIRE-1 Trial)
Published Date
Mar 1, 2022
Volume
218
Issue
3
Pages
559 - 559
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History